Arthur A. Torres - 14 Jun 2024 Form 4/A Insider Report for CareDx, Inc. (CDNA)

Reporting relationship: Director
Issuer ticker: CDNA
Reported as of: 14 Jun 2024
Net transaction value: $0
SEC form: 4/A
Accepted by SEC: 20 Jun 2024, 16:46:47 UTC
Original report date: 18 Jun 2024
Prior SEC filing: 21 Jun 2023
Next SEC filing: 17 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Arthur Torres

Key filing fact

Arthur A. Torres filed Form 4/A for CareDx, Inc. (CDNA) on 20 Jun 2024.

Key facts

This page summarizes Arthur A. Torres's Form 4/A filing for CareDx, Inc. (CDNA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 20 Jun 2024, 16:46.

Change

Previous filing in this sequence was filed on 21 Jun 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CDNA transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +16,048
Change %
Price: $0.000000
Shares after: 16,048
Date: 14 Jun 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 16,048
Exercise price: $14.19
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This amendment is being filed to correct the exercise price of the derivative security of the Stock Option (right to buy) reported on the original Form 4.

Footnote F2

1/12th of the shares subject to this option shall vest on July 14, 2024, and 1/12th of the shares subject to the option shall vest monthly thereafter through June 14, 2025.